𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preclinical and clinical studies on the cardiovascular and renal effects of fenoldopam: A DA-1 receptor agonist

✍ Scribed by Mustafa F. Lokhandwala

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
904 KB
Volume
10
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Dose-response analysis of the effects of
Dose-response analysis of the effects of fenoldopam, dopamine-1 receptor agonist, on renal function
✍ Abdallah Dlewati; Dr. Mustafa F. Lokhandwala πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 514 KB

The present study was carried out to perform a dose-response analysis of the effect of fenoldopam, a DA-1 receptor agonist, on renal sodium excretion. Infusions of fenoldopam for 30 min at doses of 0.125, 0.25, 0.5, and 1.0 pg/kg/min in four separate groups of pentobarbital-anesthetized dogs caused

Effect of chronic gestational treatment
Effect of chronic gestational treatment with the adenosine A1 receptor agonist R-phenylisopropyladenosine on metabotropic glutamate receptors/phospholipase C pathway in maternal and fetal brain
✍ David A. LeΓ³n; JosΓ© L. Albasanz; Carlos A. Castillo; Inmaculada Iglesias; Mairen πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 297 KB

## Abstract Pregnant Wistar rats were orally treated with the adenosine receptor agonist R‐phenylisopropyladenosine (R‐PIA) throughout the gestational period, and the status of the metabotropic glutamate (mGlu) receptor/phospholipase C transduction pathway from maternal and fetal brain was analyzed